Brief: Avalon Globocare Says Ava-001 Car T-Cell Therapy Clinical Trial To Include Enrollment Of Patients With Relapsed Refractory Non-Hodgkin Lymphoma

Change Agents

01/10/2020 14:18

Oct 1 (Reuters) - Avalon Globocare Corp  AVCO.O :
    * AVALON GLOBOCARE - AVA-001 CAR T-CELL THERAPY CLINICAL
TRIAL TO
INCLUDE ENROLLMENT OF PATIENTS WITH RELAPSED/REFRACTORY
NON-HODGKIN LYMPHOMA
    * AVALON GLOBOCARE - ANTICIPATE INITIATION OF HUMAN CLINICAL
TRIAL
IN PATIENTS WITH ACUTE AGVHD AND ARDS IN Q4

Source text for Eikon:  ID:nGNX4WQdpx 
Further company coverage:  AVCO.O 

 ((Reuters.Briefs@thomsonreuters.com;))